PMC:7279430 / 44167-44328 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T140","span":{"begin":94,"end":99},"obj":"Body_part"}],"attributes":[{"id":"A140","pred":"fma_id","subj":"T140","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"1,8-cineole (64.3%), α-terpineol (11.0%), and valencene (3.91%) Plaque reduction assay (Vero cells), HSV-1 92% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2305","span":{"begin":102,"end":107},"obj":"Species"}],"attributes":[{"id":"A2305","pred":"tao:has_database_id","subj":"2305","obj":"Tax:10298"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1,8-cineole (64.3%), α-terpineol (11.0%), and valencene (3.91%) Plaque reduction assay (Vero cells), HSV-1 92% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T486","span":{"begin":89,"end":93},"obj":"http://purl.obolibrary.org/obo/CLO_0009524"},{"id":"T487","span":{"begin":89,"end":93},"obj":"http://purl.obolibrary.org/obo/CLO_0050515"},{"id":"T488","span":{"begin":94,"end":99},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"1,8-cineole (64.3%), α-terpineol (11.0%), and valencene (3.91%) Plaque reduction assay (Vero cells), HSV-1 92% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T788","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"T789","span":{"begin":4,"end":11},"obj":"Chemical"},{"id":"T790","span":{"begin":23,"end":32},"obj":"Chemical"},{"id":"T791","span":{"begin":46,"end":55},"obj":"Chemical"}],"attributes":[{"id":"A788","pred":"chebi_id","subj":"T788","obj":"http://purl.obolibrary.org/obo/CHEBI_27961"},{"id":"A789","pred":"chebi_id","subj":"T789","obj":"http://purl.obolibrary.org/obo/CHEBI_23243"},{"id":"A790","pred":"chebi_id","subj":"T790","obj":"http://purl.obolibrary.org/obo/CHEBI_26876"},{"id":"A791","pred":"chebi_id","subj":"T791","obj":"http://purl.obolibrary.org/obo/CHEBI_61700"}],"text":"1,8-cineole (64.3%), α-terpineol (11.0%), and valencene (3.91%) Plaque reduction assay (Vero cells), HSV-1 92% plaque reduction (concentration not given) [66]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T356","span":{"begin":0,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1,8-cineole (64.3%), α-terpineol (11.0%), and valencene (3.91%) Plaque reduction assay (Vero cells), HSV-1 92% plaque reduction (concentration not given) [66]"}